Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05067543 · ClinicalTrials.gov registry record
Perform Humeral System Study
A clinical trial of Avascular Necrosis and Osteoarthritis Shoulder, sponsored by Stryker Trauma and Extremities.
- Recruiting
- Registry status
- 300
- Enrollment target
- 10
- Study locations
NCT05067543: Recruiting study of Avascular Necrosis and Osteoarthritis Shoulder, sponsored by Stryker Trauma and Extremities.
NCT05067543 is a study of Avascular Necrosis and Osteoarthritis Shoulder that is actively recruiting participants, run by Stryker Trauma and Extremities. The registered enrollment target is 300 participants, roughly in line with the 282-participant average among 24 other Avascular Necrosis trials with a reported enrollment target. The trial reports 10 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05067543, a study of Avascular Necrosis and Osteoarthritis Shoulder, is actively recruiting participants, sponsored by Stryker Trauma and Extremities.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 10
- Study locations
Study Summary
This study is an international, single arm, multicenter, prospective, non-significant risk, Post-Market Clinical Follow-up study, which is designed to collect safety and performance data at baseline, surgery, immediate post-op and annually through 10 years post-operation. Data collected from this study will be used for purposes, including but not limited to, Post-Market Surveillance, peer-reviewed publications, education materials, regulatory submissions, and/or product development.
Primary Outcome
ASES Score = American Shoulder and Elbow Surgeons Score, 11 items with total score reported out of 100 measuring pain and activity of patient's evaluated shoulder where lower scores indicate more pain and less function
Conditions Studied
Interventions
- DEVICE Tornier Perform Humeral - Stem
Study Locations (10)
Minnesota
- Summit Orthopedics - Eagan
- Mayo Clinic - Rochester
Other
- Orthopedic Center Santy - Lyon
- Schulthess Klinik - Zurich
Kentucky
- Baptist Healthcare - Lexington
Missouri
- Washington University - St Louis
South Dakota
- Orthopedic Institute - Sioux Falls
Utah
- University of Utah - Salt Lake City
Ontario
- Roth McFarlane Hand and Upper Limb Centre - London
Lancashire
- Wrightington Hospital - Wigan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2021-09-12 |
| Est. Completion | 2036-12-01 |
What NCT05067543 shows while recruiting
NCT05067543 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 282-participant average among 24 other Avascular Necrosis trials with a reported enrollment target.
The record links to 4 conditions, with Avascular Necrosis appearing as the primary indexed condition, and to 1 intervention - of which Tornier Perform Humeral - Stem is the first listed.
NCT05067543 lists 10 locations in 8 states (Minnesota, Other, Kentucky).
Frequently Asked Questions
What is clinical trial NCT05067543 about?
NCT05067543 is a clinical study titled "Perform Humeral System Study". This study is an international, single arm, multicenter, prospective, non-significant risk, Post-Market Clinical Follow-up study, which is designed to collect safety and performance data at baseline, surgery, immediate post-op and annually through 10 years post-operation. Data collected from this s...
What is the current status of trial NCT05067543?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2021-09-12. Estimated completion is 2036-12-01.
What conditions does trial NCT05067543 study?
This clinical trial studies the following conditions: Avascular Necrosis, Osteoarthritis Shoulder, Rotator Cuff Tear Arthropathy, Post-traumatic Arthrosis of Other Joints, Shoulder Region.
What interventions are being tested in trial NCT05067543?
The interventions under investigation include: Tornier Perform Humeral - Stem (DEVICE).
Who is sponsoring clinical trial NCT05067543?
This trial is sponsored by Stryker Trauma and Extremities, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05067543 being conducted?
This trial has 10 study locations across Kentucky, Minnesota, Missouri, South Dakota, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Avascular Necrosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05067543's enrollment target sits among peer trials
300 7th of 24 higher than 17 of 24 other Avascular Necrosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Avascular Necrosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Physica System Total Knee Replacement Registry Study
RECRUITING · NA
-
Alendronate for Osteonecrosis in Adults With Sickle Cell Disease
RECRUITING · Phase 2
-
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
RECRUITING
-
A Multi-Centre Study in Patients Undergoing Total Hip Arthroplasty With the Smith+Nephew CATALYSTEM™ Primary Hip System
ACTIVE NOT RECRUITING
-
Sickle Cell Disease (SCD) Bone Pain Study
ACTIVE NOT RECRUITING · NA
-
Pyrocarbon Clinical Follow-up Study
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI